Sean Flynn is the Senior Vice President, General Counsel, and Secretary at Vericel Corporation, a leading biotechnology company specializing in advanced therapies for sports medicine and severe burn care. In his role, Flynn is responsible for overseeing the company's legal affairs, ensuring compliance with regulatory standards, and providing strategic guidance to the executive team. His expertise in corporate governance and intellectual property law has been instrumental in navigating the complex landscape of the biotechnology industry. Before joining Vericel, Flynn held several high-profile positions in the legal field. He previously served as the Vice President and General Counsel at a prominent medical device company, where he played a key role in managing the company's legal strategy during a period of significant growth and expansion. Flynn's career also includes a stint at a top-tier law firm, where he specialized in life sciences and healthcare law, advising clients on a wide range of legal matters, from mergers and acquisitions to patent litigation. His diverse experience and deep understanding of the industry have made him a valuable asset to Vericel. Under Flynn's leadership, Vericel has successfully navigated numerous legal challenges and strengthened its position in the market. His strategic vision and commitment to ethical practices have helped the company maintain a strong reputation and foster trust among investors and stakeholders. Flynn's contributions have been crucial in driving Vericel's mission to develop innovative therapies that improve patients' lives, cementing his role as a vital member of the company's leadership team.